Loading...
Toggle navigation
Home
About
Editorial Board
Current Editorial Board
Young Editorial Board
Invited Reviewers
Instruction
Authors Instruction
Ethics
Peer Review & Editing
Correction & Retraction
Open Access
Copyright & Archive
Guideline
Manuscript Guideline
Ethic Guideline
Template Download
Journal
Current Issue
Archive
Highlights
Cooperation
Council Members
Advertisement
Subscription
Print Subscription
Email Alert
Contact Us
中文
Office Online
Author Login
Peer Review
Editor-in-Chief
Office Work
Directed by: Shanghai Academy of Science and Technology
Sponsored by: Shanghai Laboratory Animal Science Association
Shanghai Laboratory Animal Research Center
Editor-in-Chief: WANG Jian
Postal code:4-789
ISSN 1674-5817
CN 31-1954/Q
Search
Paper Search
Issue Search
Advanced Search
Links
China Laboratory Animal Information Network
Shanghai Laboratory Animal Science Association
Shanghai Laboratory Animal Research Center
Shanghai Academy of Science & Technology
CNKI
Wanfang Med Online
PubMed
DOAJ
Laboratory Animals
Comparative Medicine
Animal Models and Experimental Medicine
Acta Laboratorium Animalis Scientia Sinica
Chinese Journal of Comparative Medicine
Chinese Library Classification Code
Term Online
More>>
Table of Content
25 September 1987, Volume 7 Issue 3
Previous Issue
Next Issue
The Incidence of Spontaneously occurring Tumors in TR1 and TR 2 Rats
LIN Bing-Shui, DOU Gui-Rong, WANG Dong-Mao, ZHANG Yu-Ying, CUI Zhen-Huan, LUAN Shu-Zhi
1987, 7(3): 131-132.
Asbtract
(
644
)
PDF
(3603KB) (
391
)
Related Articles
|
Metrics
The incidence of spontaneously occurring tumors in the selected TR 1 and TR 2 inbred strain rats was observed over two years and reported the results of histological examinations as follow. The TR l rats used were 288 (□105;♀ 183) Mammary gla-nd fibroadenomas in the TR 1 rats were 9.3% (♀)and 1.0% (□),mammary gland adenocarcinomas 1.6% (♀),lung adenomas 1.6% (♀) and 2.9% (□). The TR 2 rats used were 336 (□186;♀150).Mammary gland fibroadenomas were 13.3%(♀) and 2.2%(□), mammary gland adenocarcinomas 2.7% (♀) and 0.5% (□), lung adenomas 0.7% (♀) and hepatomas 0.3% (1/336)。